News 2010

DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the Company will be participating at the Surfaces in Biomaterials Foundation’s 2010 BioInterface Symposium and Workshop, which will be held October 18 – 20 in Atlanta, Georgia.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and DuPont announce an agreement to form a joint venture to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval.  The joint venture will be named Actamax Surgical Materials LLC. Under the joint venture agreement, DSM and DuPont will each share a 50 percent interest.

DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the company has extended its partnership with Spinelab Ltd., a privately held company specialized in developing a dynamic stabilization system for the spine.

DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the company has entered into six multi-year licensing agreements with global medical device manufacturers in the Orthopedic, Cardiovascular, Vascular and Urology fields in this year alone.

DSM Biomedical, a global leader in biomedical materials science, announced today Mr. Christophe Dardel’s appointment as President effective May 21, 2010. Mr. Dardel succeeds Mr. Steve Hartig who served as the Company’s president since 2006.

DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the Company will both exhibit and present at the upcoming Medical Design and Manufacturing East Conference & Exposition (MD&M East) held June 7 – 10, 2010 at the Jacob K. Javits Convention Center in New York City.

DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, will be participating at ARVO 2010 (Booth #813) to provide attendees with an in-depth look at the company’s expanding portfolio of biomedical materials, customized drug delivery systems, contract R&D and manufacturing services for ophthalmic applications.

DSM Biomedical, a global leader in biomedical materials science, today announced the extension of its partnership with CID based on the use of DSM ComfortCoat® Hydrophilic coating technology on the Optima Jet Stent Delivery System and the Fluydo PTCA Balloon Catheter, both with CE mark and launched on the European market last month.

DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States (U.S.) and Europe to support the growing demand for the company’s portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.

DSM PTG, part of DSM Biomedical, a global leader in biomedical materials science, today announced the company has formed eight new partnerships with medical device companies in the last year alone.